Scarica l'app Stockscreener
529.24
1.42%
7.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché REGN Giù?
Forum
Previsione
Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie
Asio Capital LLC Has $2.53 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Increased by Factory Mutual Insurance Co. - MarketBeat
Regeneron, Sanofi Announce Positive Dupixent Results for Atopic Dermatitis - Insider Monkey
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Wedmont Private Capital Lowers Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Handelsbanken Fonder AB - MarketBeat
New England Research & Management Inc. Invests $384,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron (REGN) Chosen as Backup Bidder in 23andMe Asset Sale | - GuruFocus
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Fifth Third Bancorp - MarketBeat
1,547 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Harbor Capital Advisors Inc. - MarketBeat
Regeneron’s SWOT analysis: stock faces eylea challenges, pipeline potential - Investing.com
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Miracle Mile Advisors LLC - MarketBeat
Tounjian Advisory Partners LLC Invests $662,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Research Analysts Offer Predictions for REGN FY2026 Earnings - MarketBeat
23andMe co-founder Anne Wojcicki has bought back the company - NewsBytes
23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm - MSN
Atwood & Palmer Inc. Has $26.62 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Anne Wojcicki to buy back 23andMe and its data for $305 million - MSN
Regeneron requests bundling ban after trial win - Global Competition Review
Former 23andMe CEO wins bidding war against Regeneron - FirstWord
23andMe's founder Anne Wojcicki wins bid for DNA testing firm - MSN
23andMe founder buys back genetic testing company in second auction - Financial Times
23andMe’s founder Anne Wojcicki wins bid for bankrupt DNA testing firm - New York Post
23andMe’s founder Anne Wojcicki wins bid for DNA testing firm - The Mighty 790 KFGO
Anne Wojcicki wins back 23andMe in bankruptcy court sale - The Business Journals
Regeneron (REGN) Chosen as Backup Bidder in 23andMe Asset Sale | REGN Stock News - GuruFocus
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process - Benzinga
Avanza Fonder AB Has $5.57 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
JPMorgan Calls the Selloff Excessive, Trims Regeneron Pharmaceuticals, Inc. (REGN) Price Target - MSN
Smithbridge Asset Management Inc. DE Invests $3.41 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
NorthCrest Asset Manangement LLC Has $7.55 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
2,141 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by RMR Wealth Builders - MarketBeat
Pallas Capital Advisors LLC Takes $426,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Breakthroughs in Autoimmune Treatment Propel Interleukin - openPR.com
Consumer sentiment, Regeneron meeting, Apple WWDC: What to Watch - Yahoo Finance
Is This Stock a Buy After Acquiring a Potential Zepbound Competitor? - MSN
Regeneron Genetics Center Selects Olink® Explore HT for Landmark Proteomics Study of 200,000 Patient Samples - BioSpace
Greenwood Capital Associates LLC Invests $5.35 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Monitoring Eylea Biosimilar Closely Following Innovative Setbacks - insights.citeline.com
When (REGN) Moves Investors should Listen - news.stocktradersdaily.com
Merit Financial Group LLC Buys 761 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Licenses Weight Loss Drug and Shares Muscle Preservation Study Data as Bluebird Bio Goes Private - geneonline.com
TB Alternative Assets Ltd. Acquires New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MSN
Assenagon Asset Management S.A. Has $305.31 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
What’s Regeneron’s $256 Million Plan for 23andMe? - River Journal Online
Lake Hills Wealth Management LLC Purchases Shares of 616 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
1.09%
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):